Yoshida K, Gould K L
Department of Medicine, University of Texas Medical School at Houston 77030.
J Am Coll Cardiol. 1993 Oct;22(4):984-97. doi: 10.1016/0735-1097(93)90407-r.
The purpose of this study was to determine the clinical prognostic value, with and without revascularization, of the size of myocardial infarction and viability as measured by positron emission tomography (PET).
Poorly contracting but viable myocardium recovers contractile performance after revascularization. However, the quantitative relation among size of infarction and viability by PET, ejection fraction and long-term survival with and without revascularization in patients after myocardial infarction has not been previously reported.
Infarct size and viability imaged by PET using generator-produced rubidium-82 were quantified objectively by automated software and related to coronary arteriography, left ventricular ejection fraction, revascularization and 3-year mortality.
Myocardial infarction or scar > or = 23% of the left ventricle was associated with a 3-year mortality rate of 43% versus that of 5% associated with scar < 23% of the left ventricle (p = 0.014). An ejection fraction < or = 43% correlated with a 3-year mortality rate of 38% compared with 6% for an ejection fraction > or = 43% (p = 0.029) because infarct size > or = 23% of the left ventricle was also associated with an ejection fraction < or = 43%. For patients with a low ejection fraction (< or = 43%) or large infarcts/scar (> or = 23% of the left ventricle), ejection fraction value or infarct size did not predict mortality. However, in patients with an ejection fraction < or = 43%, the absence of viable myocardium in arterial zones at risk was associated with a mortality rate of 63% versus 13% in subjects with viable myocardium, a difference with only a 5.9% probability of occurring by chance alone (p = 0.059). For all patients with viable myocardium in arterial zones at risk, the mortality rate was 8%, and 80% had revascularization over 3 years. For patients with only fixed scar in arterial zones at risk, the mortality rate was 50% versus 8% (p = 0.018), and 40% had revascularization, with no difference in mortality with or without revascularization, thereby suggesting no benefit in this subgroup.
Size of scar and viable myocardium by PET in arterial zones at risk in patients after myocardial infarction are highly predictive of 3-year mortality, particularly in patients with low ejection fraction, and identify patients who are suitable candidates for revascularization after myocardial infarction.
本研究旨在确定通过正电子发射断层扫描(PET)测量的心肌梗死大小和存活心肌在有或无血运重建情况下的临床预后价值。
收缩功能差但存活的心肌在血运重建后可恢复收缩功能。然而,心肌梗死后患者中,PET测量的梗死大小与存活心肌、射血分数以及有或无血运重建情况下的长期生存率之间的定量关系此前尚未见报道。
使用发生器产生的铷-82通过PET成像的梗死大小和存活心肌由自动化软件进行客观量化,并与冠状动脉造影、左心室射血分数、血运重建及3年死亡率相关联。
左心室心肌梗死或瘢痕面积≥23%与3年死亡率43%相关,而瘢痕面积<23%的左心室患者3年死亡率为5%(p = 0.014)。射血分数≤43%与3年死亡率38%相关,而射血分数≥43%的患者3年死亡率为6%(p = 0.029),因为左心室梗死面积≥23%也与射血分数≤43%相关。对于射血分数低(≤43%)或梗死/瘢痕大(≥左心室的23%)的患者,射血分数值或梗死大小不能预测死亡率。然而,在射血分数≤43%的患者中,有风险动脉区域无存活心肌者死亡率为63%,而有存活心肌者死亡率为13%,这种差异仅由偶然因素导致的概率为5.9%(p = 0.059)。对于所有有风险动脉区域存在存活心肌的患者,死亡率为8%,且80%在3年内接受了血运重建。对于有风险动脉区域仅有固定瘢痕的患者,死亡率为50%,而接受血运重建者死亡率为8%(p = 0.018),血运重建与否死亡率无差异,因此提示该亚组患者无获益。
心肌梗死后患者有风险动脉区域通过PET测量的瘢痕大小和存活心肌对3年死亡率具有高度预测性,尤其对于射血分数低的患者,并可识别出心肌梗死后适合进行血运重建的患者。